<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
	"http://www.w3.org/TR/1998/REC-html40-19980424/loose.dtd">
<html>
<head><meta http-equiv="content-type" content="text/html; charset=UTF-8">
<style type="text/css">
 table.main {}
 tr.row {}
 td.cell {}
 div.block {}
 div.paragraph {}
 .font0 { font:4pt Arial, sans-serif; }
 .font1 { font:5pt Arial, sans-serif; }
 .font2 { font:7pt Arial, sans-serif; }
 .font3 { font:10pt Arial, sans-serif; }

</style>
</head>
<body>
<p><span class="font3">Morgan Stanley </span><span class="font0" style="font-weight:bold;">RESEARCH</span></p>
<p><span class="font1" style="font-weight:bold;">FOUNDATION</span></p>
<p><span class="font2">the base business, while we see upside risk to Palette on international expansion and shifting landscape across radiotherapy reimbursement in the US. For PODD, we think GLP-1 fears are especially overdone, with the stock down &gt;40% despite strong numbers and c. 85% exposure to type 1. 2024 has a series of growth drivers, from iOS integration to Libre connection, and at c. 6x sales we think the shares are too cheap vs key peers. We also remain bullish or MDT (Top Pick) despite strong relative performance YTD, with the company still under-owned due to historical execution challenges but one of the best pipelines of new launches in the industry over the next 12-18 months and solid balance sheet. For Overweight SIBN (Top Pick) we see several tailwinds driving upside to '24, as well as clear leverage improvements on the path to profitability.</span></p>
<p><span class="font2">Hospital capital spending survey shows 2024 spending levels will be consistent y/y, driven by increasing patient volume expectations paired against rising costs. Our survey (here) of over 100 hospital executives shows '24 capital spending is expected to advance 3.8% y/y, largely in Line with expectations for '23 (+4%). Most hospitals anticipate increased purchasing across all surveyed categories, though there are apparent shifting spend priorities. Soft-tissue robotics purchasing looks well protected, and there's an uptick in expected orthopedic robotic spend, though dialysis machines appear to be less of a '24 spending priority. Hospitals continue to experience pent-up demand, though the backlog appears to be improving with 60% of respondents saying Less than 50% of the overall pent-up demand remain. Furthermore, only12% of respondents indicated their hospital's current elective backlog is trending above Levels experienced three-months ago. Also, worth noting, two-thirds of hospitals expect to increase investments in ambulatory surgery centers (ASCs), while another 34% will keep spending unchanged. Roughly 60% of respondents agree that working with a single ASC vendor is important.</span></p>
<div>
<table border="1">
<tr><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Rating</span></p>
<p><span class="font2" style="font-weight:bold;">Price Target</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">NA $0.00</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Overweight $36.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Vicarious Surgical Inc (RBOT.N) Rating</span></p>
<p><span class="font2" style="font-weight:bold;">Price Target</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2" style="font-weight:bold;">From NA $0.00</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2" style="font-weight:bold;">To Equal-weight $0.60</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Bausch + Lomb Corp (BLCO.N) Price Target</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">From $17.00</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">To $16.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Baxter International (BAX.N) Price Target</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">From $45.00</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">To $39.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Becton Dickinson (BDX.N) Price Target</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">From $310.00</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">To $280.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Cooper Companies Inc (COO.O) Price Target</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2" style="font-weight:bold;">From $410.00</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2" style="font-weight:bold;">To $355.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">GE Healthcare Technologies</span></p>
<p><span class="font2" style="font-weight:bold;">Inc(GEHC.O)</span></p>
<p><span class="font2" style="font-weight:bold;">Price Target</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2" style="font-weight:bold;">From $78.00</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2" style="font-weight:bold;">To $74.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Intuitive Surgical Inc. (ISRG.O) Price Target</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">From $300.00</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">To $330.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">NeuroPace Inc (NPCE.O)</span></p>
<p><span class="font2" style="font-weight:bold;">Price Target</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">From</span></p>
<p><span class="font2" style="font-weight:bold;">$8.00</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">To $9.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Outset Medical, Inc. (OM.O)</span></p>
<p><span class="font2" style="font-weight:bold;">Price Target</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">From</span></p>
<p><span class="font2" style="font-weight:bold;">$5.00</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">To $5.50</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Sight Sciences Inc (SGHT.O) Price Target</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">From $3.00</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">To $4.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">STERISplc(STE.N)</span></p>
<p><span class="font2" style="font-weight:bold;">Price Target</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">From $225.00</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">To $215.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Stryker Corporation (SYK.N) Price Target</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">From $300.00</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">To $320.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Transmedics Group Inc (TMDX.0) Price Target</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2" style="font-weight:bold;">From $54.00</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2" style="font-weight:bold;">To $75.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Boston Scientific (BSX.N) Price Target</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">From $58.00</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">To $61.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Zimmer Biomet Holdings Inc (ZBH.N) Price Target</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2" style="font-weight:bold;">From $120.00</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2" style="font-weight:bold;">To $125.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">DexCom Inc(DXCM.O)</span></p>
<p><span class="font2" style="font-weight:bold;">Price Target</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">From $101.00</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">To $122.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Edwards Lifesciences (EW.N) Price Target</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">From $102.00</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">To $80.00</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Shockwave Medical Inc.</span></p>
<p><span class="font2" style="font-weight:bold;">(SWAV.O)</span></p>
<p><span class="font2" style="font-weight:bold;">Price Target</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">From $284.00</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">To $223.00</span></p></td></tr>
</table>
</div><br clear="all">
<div>
</div><br clear="all">
<div>
</div><br clear="all">
<div>
</div><br clear="all">
<div>
</div><br clear="all">
<p><span class="font2" style="font-weight:bold;">2</span></p>
</body>
</html>